The German Pharmaceutical Industry Association (BPI) welcomes the aim of the EU Stockpiling Strategy (EUSS) to develop a coordinated European approach to stockpiling critical medical countermeasures (MCMs). In light of increasing geopolitical uncertainty and emerging threats, strengthening the EU’s crisis preparedness is vital. Establishing resilient supply chains and building strategic reserves of MCMs will enable authorities to maintain societal functioning and safeguard public health during emergencies.
